Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -5.63x is 62% above its 5-year average of -14.66x, near the high end of its 5-year range (-4365.28x–7.89x).
99.37% above its 12-month average of -887.72x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -4365.28x.
INTEREST COVERAGE RATIO
-5.63x
INTEREST COVERAGE RATIO AVG TTM
-887.72x
INTEREST COVERAGE RATIO AVG 3Y
-10.91x
INTEREST COVERAGE RATIO AVG 5Y
-14.66x
INTEREST COVERAGE RATIO AVG 10Y
-21.31x
INTEREST COVERAGE RATIO AVG 15Y
-17.87x
INTEREST COVERAGE RATIO AVG 20Y
-6.13x
CURRENT VS TTM AVG
+99.37%
CURRENT VS 3Y AVG
+48.40%
CURRENT VS 5Y AVG
+61.60%
CURRENT VS 10Y AVG
+73.58%
CURRENT VS 15Y AVG
+68.49%
CURRENT VS 20Y AVG
+8.20%
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+11.69%
vs the sector median at left
Cumberland Pharmaceuticals Inc.
Market Cap
$106.98M
Interest Coverage Ratio
-5.63x
TTM Avg
-887.72x
3Y Avg
-10.91x
5Y Avg
-14.66x
Market Cap
$106.91M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$108.59M
Interest Coverage Ratio
-236.86x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$108.66M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$108.76M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$105.07M
Interest Coverage Ratio
-1.82x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$104.86M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$104.62M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cumberland Pharmaceuticals Inc. (CPIX) | $106.98M | -5.63x | -887.72x | -10.91x | -14.66x |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $106.91M | N/A | N/A | N/A | N/A |
| Immunic, Inc. (IMUX)vs › | $107.06M | N/A | N/A | N/A | N/A |
| Outlook Therapeutics, Inc. (OTLK)vs › | $108.59M | -236.86x | N/A | N/A | N/A |
| Vivani Medical, Inc. (VANI)vs › | $108.66M | N/A | N/A | N/A | N/A |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $108.76M | N/A | N/A | N/A | N/A |
| Definitive Healthcare Corp. (DH)vs › | $105.07M | -1.82x | N/A | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $104.86M | N/A | N/A | N/A | N/A |
| Anixa Biosciences, Inc. (ANIX)vs › | $104.62M | N/A | N/A | N/A | N/A |
| Apyx Medical Corporation (APYX)vs › | $109.70M | -1.15x | 4.51x | 6.93x | 222.11x |
Interest Coverage
-5.6x
Debt/Equity
0.27
Current Ratio
0.96
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -4365.28x |
| 2026-03-31 | -36.46x |
| 2025-12-31 | -12.14x |
| 2025-09-30 | -17.92x |
| 2025-06-30 | -6.82x |
| 2025-03-31 | 7.89x |
| 2024-12-31 | -8.25x |
| 2024-09-30 | -12.33x |
| 2024-06-30 | -8.13x |
| 2024-03-31 | -15.77x |
| 2023-12-31 | -34.56x |
| 2023-09-30 | -16.96x |
| 2023-06-30 | 0.12x |
| 2023-03-31 | -8.22x |
| 2022-12-31 | -12.69x |
| 2022-09-30 | -1.93x |
| 2022-06-30 | -13.42x |
| 2022-03-31 | -10.80x |
| 2021-12-31 | -156.99x |
| 2021-09-30 | -78.09x |
| 2021-06-30 | -55.52x |
| 2021-03-31 | -13.28x |
| 2020-12-31 | -48.64x |
| 2020-09-30 | -16.07x |
| 2020-06-30 | -13.23x |
| 2020-03-31 | -55.83x |
| 2019-12-31 | -34.16x |
| 2019-09-30 | -28.47x |
| 2019-06-30 | -6.60x |
| 2019-03-31 | -2.90x |
| 2018-12-31 | -16.60x |
| 2018-09-30 | -94.11x |
| 2018-06-30 | -39.46x |
| 2018-03-31 | -133.99x |
| 2017-12-31 | -40.58x |
| 2017-09-30 | -94.29x |
| 2017-06-30 | -55.97x |
| 2017-03-31 | -20.74x |
| 2016-12-31 | -33.46x |
| 2016-09-30 | 4.47x |
| 2016-06-30 | -3.73x |
| 2016-03-31 | -24.49x |
| 2015-12-31 | -8.13x |
| 2015-09-30 | 13.67x |
| 2015-06-30 | 36.45x |
| 2015-03-31 | 0.26x |
| 2014-12-31 | 60.20x |
| 2014-09-30 | 36.80x |
| 2014-06-30 | 99.01x |
| 2014-03-31 | 33.44x |
| 2013-12-31 | -60.74x |
| 2013-09-30 | -62.37x |
| 2013-06-30 | -55.10x |
| 2013-03-31 | 74.77x |
| 2012-12-31 | 208.31x |
| 2012-09-30 | 172.99x |
| 2012-06-30 | 116.02x |
| 2012-03-31 | 28.81x |
| 2011-12-31 | 69.96x |
| 2011-09-30 | 92.79x |
| 2011-06-30 | 45.62x |
| 2011-03-31 | 6.52x |
| 2010-12-31 | 18.07x |
| 2010-09-30 | 4.46x |
| 2010-06-30 | 2.49x |
| 2010-03-31 | 2.34x |
| 2009-12-31 | 2.02x |
| 2009-09-30 | 9.55x |
| 2009-06-30 | 7.05x |
| 2009-03-31 | 21.67x |
| 2008-12-31 | 36.87x |
| 2008-09-30 | 44.21x |
| 2008-06-30 | 177.17x |
| 2008-03-31 | 15.79x |
| 2007-12-31 | 9.96x |
| 2007-09-30 | 13.91x |
| 2007-06-30 | 12.55x |
| 2007-03-31 | 6.51x |
| 2006-12-31 | 4.60x |
| 2006-09-30 | 7.69x |
| 2006-06-30 | 3.45x |
| 2006-03-31 | -17.55x |